Erratum: Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice (Endocrine DOI 10.1007/s12020-011-9438-5);Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice

Endocrine

Volumn 40, Issue 1, 2011, Pages 41-54

  Weiss, Lola ^a   Bernstein, Steve ^b   Jones, Richard ^c   Amunugama, Ravi ^c   Krizman, David ^d   JeBailey, Lellean ^e   Hazan, Osnat ^a   Yachtin, Janna ^a   Shiner, Reut ^a   Reibstein, Israel ^a   Triche, Elizabeth ^g   Slavin, Shimon ^f   Or, Reuven ^a   Barnea, Eytan R ^h,i  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b QualTek Molecular Laboratories   (United States)

^c NextGen Sciences Ltd   (United States)

^d Expression Pathology Inc ^*  (United States)

^e GeneGo bioinformatics software Inc   (United States)

^f International Center for Cell Therapy and Cancer Immunotherapy CTCI   (Israel)

^g BROWN UNIVERSITY   (United States)

^h Society for the Investigation of Early Pregnancy (SIEP)   (United States)

ⁱ RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

NOD; Pancreas; Preimplantation factor; Therapy; TIDM

Indexed keywords

ACTIN; GAMMA INTERFERON; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOMODULATING AGENT; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; METHIONYLVALYLARGINYLISOLEUCYLLYSYLPROLYLGLYSYLSERYLALANYLASPARAGINYLLYSYLPROLYLSERYLASPARTYLASPARTIC ACID; SYNTHETIC PEPTIDE; TUBULIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL INVASION; CELL STRUCTURE; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE URINE LEVEL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; LOW DRUG DOSE; MASS SPECTROMETRY; MOUSE; NEUTROPHIL; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PANCREAS FUNCTION; PANCREAS ISLET; PRIORITY JOURNAL; PROTECTION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN TRANSPORT; PROTEOMICS; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TREATMENT DURATION;

EID: 80755189023     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9464-3     Document Type: Erratum

References (44)

1. M.M. Lederman, J.J. Ellner, H.M. Rodman, J. Immunol. 127, 2051-2055 (1981).
2. M. Asano, M. Toda, N. Sakaguchi, S. Sakaguchi, J. Exp. Med. 184, 387-396 (1996).
3. B. Salomon, D.J. Lenschow, L. Rhee, N. Ashourian, B. Singh, A. Sharpe, J.A. Bluestone, Immunity 12, 431-440 (2000).
4. D. Bresson, M. von Herrath, Drug Discov. Today Dis. Mech. 1, 321-327 (2004).
5. J.J. Devoss, A.K. Shum, K.P. Johannes, W. Lu, A.K. Krawisz, P. Wang, T. Yang, N.P. Leclair, C. Austin, E.C. Strauss, M.S. Anderson, J. Immunol. 181, 4072-4079 (2008).
6. D. Pitocco, F. Zaccardi, E. Di Stasio, F. Romitelli, F. Martini, G.L. Scaglione, D. Speranza, S. Santini, C. Zuppi, G. Ghirlanda, Diabetes Res. Clin. Pract. 86(3), 173-176 (2009).
7. R.A. Ritzel, Front. Biosci. 14, 1835-1850 (2009). Review.
8. K.C. Herold, W. Hagopian, J.A. Auger, E. Poumian-Ruiz, L. Taylor, D. Donaldson, S.E. Gitelman, D.M. Harlan, D. Xu, R.A. Zivin, J.A. Bluestone,N. Engl. J. Med. 346, 1692-1698 (2002).
9. G.S. Eisenbarth, S. Srikanta, R. Jackson, S. Rabinowe, R. Dolinar, T. Aoki, M.A. Morris, Diabetes Res. 2, 271-276 (1985).
10. I. Raz, D. Elias, A. Avron, M. Tamir, M. Metzger, I.R. Cohen, Lancet 358, 1749-1753 (2001).
11. M. Bitan, L. Weiss, M. Zeira, S. Reich, O. Pappo, S. Vlodavsky, S. Slavin, Diabetes Metab. Res. Rev. 24, 413-421 (2008).
12. L. Weiss, S. Slavin, S. Reich, P. Cohen, S. Shuster, R. Stern, E. Kaganovsky, E. Okon, A.M. Rubinstein, D. Naor, Proc. Natl. Acad. Sci. USA 97, 285-290 (2000).
13. G. Elkin, T.B. Prigozhina, S. Slavin, Prevention of TIDM in nonobese diabetic mice by non myeloablative allogenic bone marrow transplantation. Exp. Hematol. 32, 579-584 (2004). (Pubitemid 38739470)
14. M. Koulmanda, E. Budo, S. Bonner-Weir, A. Qipo, P. Putheti, N. Degauque, H. Shi, Z. Fan, J.S. Flier, H. Auchincloss Jr., X.X. Zheng, T.B. Strom, Proc. Natl. Acad. Sci. USA 104, 13074-13079 (2007).
15. B. Runmarker, O. Andersen, Brain 188, 253-261 (1995).
16. A. Doria, L. Iaccarino, S. Arienti, A. Ghirardello, S. Zampieri, M.E. Rampudda, S. Cutolo, A. Tincani, S. Todesco, Reprod. Toxicol. 2, 234-241 (2006). Review.
17. C. Huang, F. Snider, J.C. Cross, Endocrinology. 150, 1618-1626 (2009). Epub 2008 Nov 26.
18. M. Ostensen, F. Forger, BMJ 328, 915 (2004).
19. E. R. Barnea, R. Perez, P. C. Leavis, Assays for preimplantation factor and preimplantation factor peptides. USPTO 7,273,708 B2. September 2007.
20. E.R. Barnea, J. Simon, S.P. Levine, C.B. Coulam, G.S. Taliadouros, P.C. Leavis, Am. J. Reprod. Immunol. 42, 95-99 (1999).
21. E.R. Barnea, Am. J. Reprod. Immunol. 51, 319-322 (2004).
22. E.R. Barnea, Ann. N. Y. Acad. Sci. 1110, 602-618 (2007).
23. E.R. Barnea, S. Sharma, Prediction of implantation in ART using molecular biology, in Contemporary Perspectives on Assisted Reproductive Technology, ed. by G.N. Allahbadia, R. Merchant (Reed Elsevier, India, 2007), pp. 183-194.
24. E. R. Barnea, in Signaling Between Embryo and Mother in Early Pregnancy: Basis for Development of Tolerance. ed. by H. Carp. Recurrent Pregnancy Loss (Taylor & Francis, London) pp. 15-22.
25. E. R. Barnea, D. Kirk, PIF modulated gene expression in human Peripheral Blood Mononuclear Cell (PBMC) (Homo sapiens GSE18291 [Accession]) (2009), www.ncbi.nlm.nih.gov.
26. M. J. Paidas, G. Krikun, J. Huang, R. Jones, M. Romano, J. Annunziato, E. R. Barnea, Am. J. Obstet. Gynecol. 202, 459.e1-459.e8 (2010).
27. C. Duzyj, E. R. Barnea, M. Li, S. J. Huang, G. Krikun, M. J. Paidas, Am J Obstet Gynecol, 203, 402.e1-402.e4 (2010). Epub 2010 Aug 12.
28. M. Jurewicz, S. Yang, A. Augello, J. G. Godwin, R. F. Moore, J. Azzi, P. Fiorina, M. Atkinson, M. H. Sayegh, R. Abdi, Diabetes (2010). Sept 2010 Ahead of print.
29. R. Geoffrey, S. Jia, A.E. Kwitek, J. Woodliff, S. Ghosh, A. Lernmark, X. Wang, M.J. Hessner, J. Immunol. 177, 7275-7286 (2006).
30. A.D. Recklies, C. White, H. Ling, Biochem. J. 365, 119-126 (2002).
31. B. Zhong, P. Strand, D.M. Toivola, G.Z. Tao, X. Ji, H.B. Greenberg, M.B. Omary, Mol. Biol. Cell 18, 4969-4978 (2007).
32. L.G. Xu, M. Wu, J. Hu, Z. Zhai, H.B. Shu, J. Leukoc. Biol. 72, 410-416 (2002).
33. J. M. Fernández-Real, F. Equitani, J. M. Moreno, M. Manco, F. Ortega, W. Ricart. J. Clin. Endocrinol. Metab. (2008) Dec 30. [Epub ahead of print].
34. I.C. Gerling, S. Sudhir, N.I. Lenchik, D.R. Marshall, J. Wu, Mol. Cell. Proteomics 5, 293-306 (2006).
35. K.S. Na, B.C. Park, M. Jang, S. Cho, H. do Lee, S. Kang, C.K. Lee, K.H. Bae, S.G. Park, Mol Cells 24, 261-267 (2007).
36. S.S. Solomon, N. Buss, J. Shull, S. Monnier, G. Majumdar, J. Wu, C. Gerling, J. Lab. Clin. Med. 145, 275-283 (2005).
37. D.C. Thurmond, C. Gonelle-Gispert, M. Furukawa, P.A. Halban, J.E. Pessin, Mol. Endocrinol. 17, 732-742 (2003).
38. Y.W. Chang, J.A. Traugh, M. Li, Mol. Cell. Biol. 28, 4549-4561 (2008).
39. R.R. Ramos, A.J. Swanson, J. Bass, Proc. Natl. Acad. Sci. 104, 10470-10475 (2007).
40. P. Yang, M. Li, D. Guo, F. Gong, B.L. Adam, M.A. Atkinson, C.Y. Wang, Ann. N. Y. Acad. Sci. 1150, 68-71 (2008).
41. R.M. Szmola, C. Sahin-Tóth, Proc. Natl. Acad. Sci. 104, 11227-11232 (2007).
42. T.M. Hansner, M. Kauer, G. Gornitzka, H. Kolb, S. Martin, Exp. Clin. Endocrinol. Diab. 112, 288-293 (2004).
43. A. E.Handel, L. Handunethi, G. C. Ebers, S. V. Ramagopalan, Nat Rev Endocrinol. 5(12), 655-664 (2009). Epub 2009 Nov
44. B. H. Choi, S. J. Hahn, Acta Pharmacol. Sin (2010) 31, 1031-1035